TopicNeuroscience

pharmacological interventions

Latest

SeminarNeuroscience

How Intermittent Bioenergetic Challenges Enhance Brain and Body Health

Mark Mattson
Johns Hopkins University School of Medicine
Sep 26, 2023

Humans and other animals evolved in habitats fraught with a range of environmental challenges to their bodies and brains. Accordingly, cells and organ systems possess adaptive stress-responsive signaling pathways that enable them to not only withstand environmental challenges, but also to prepare for future challenges and function more efficiently. These phylogenetically conserved processes are the foundation of the hormesis principle in which repeated exposures to low to moderate amounts of an environmental challenge improve cellular and organismal fitness. Here I describe cellular and molecular mechanisms by which cells in the brain and body respond to intermittent fasting and exercise in ways that enhance performance and counteract aging and disease processes. Switching back and forth between adaptive stress response (during fasting and exercise) and growth and plasticity (eating, resting, sleeping) modes enhances the performance and resilience of various organ systems. While pharmacological interventions that engage a particular hormetic mechanism are being developed, it seems unlikely that any will prove superior to fasting and exercise.

SeminarNeuroscience

Neural stem cells as biomarkers of cognitive aging and dementia

Sandrine Thuret
King's College London, Institute of Psychiatry, Psychology & Neuroscience, Basic & Clinical, Neuroscience Department
Jun 25, 2021

Adult hippocampal neurogenesis is implicated in memory formation and mood regulation. The Thuret lab investigates environmental and molecular mechanisms controlling the production of these adult-born neurons and how they impact mental health. We study neurogenesis in healthy ageing as well as in the context of diseases such as Alzheimer’s and depression. By approaching neurogenesis in health and disease, the strategy is two folds: (i) Validating the neurogenic process as a target for prevention and pharmacological interventions. (ii) Developing neurogenesis as a biomarker of disease prediction and progression. In this talk, I will focus on presenting some recent human studies demonstrating how hippocampal neural stem cells fate can be used as biomarkers of cognitive aging and dementia.

pharmacological interventions coverage

2 items

Seminar2

Share your knowledge

Know something about pharmacological interventions? Help the community by contributing seminars, talks, or research.

Contribute content
Domain spotlight

Explore how pharmacological interventions research is advancing inside Neuroscience.

Visit domain

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.